Cargando…
ATXN3 promotes prostate cancer progression by stabilizing YAP
BACKGROUND: Prostate cancer (PC) is the most common neoplasm and is the second leading cause of cancer-related deaths in men worldwide. The Hippo tumor suppressor pathway is highly conserved in mammals and plays an important role in carcinogenesis. YAP is one of major key effectors of the Hippo path...
Autores principales: | Wu, Longxiang, Ou, Zhenyu, Liu, Peihua, Zhao, Cheng, Tong, Shiyu, Wang, Ruizhe, Li, Yangle, Yuan, Junbin, Chen, Minfeng, Fan, Benyi, Zu, Xiongbing, Wang, Yongjie, Tang, Jianing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286397/ https://www.ncbi.nlm.nih.gov/pubmed/37349820 http://dx.doi.org/10.1186/s12964-023-01073-9 |
Ejemplares similares
-
SOX5 promotes cell growth and migration through modulating DNMT1/p21 pathway in bladder cancer: SOX5/DNMT1/p21 pathway in BC
por: Wu, Longxiang, et al.
Publicado: (2022) -
ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion
por: Wu, Longxiang, et al.
Publicado: (2019) -
m(6)A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism
por: Liu, Peihua, et al.
Publicado: (2022) -
Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma
por: Li, Yangle, et al.
Publicado: (2021) -
S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8(+) T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2023)